Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.39+0.17 (+5.28%)
Close on Nov 18, 2026Market cap $655.07MP/E –Yield –
Inventiva revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was €4.48M, down 51.3% from the year before. The highest annual figure on record is €17.48M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €4.48M | -51.3% |
| FY2024 | Dec 31, 2024 | €9.20M | -47.4% |
| FY2023 | Dec 31, 2023 | €17.48M | +43.5% |
| FY2022 | Dec 31, 2022 | €12.18M | +190.4% |
| FY2021 | Dec 31, 2021 | €4.19M | +1027.4% |
| FY2020 | Dec 31, 2020 | €372.00K | -94.7% |
| FY2019 | Dec 31, 2019 | €7.00M | +118.9% |
| FY2018 | Dec 31, 2018 | €3.20M | – |
See a number that looks wrong?